EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Improved Locoregional Recurrence‐Free Survival With Carbon Ion Versus Photon Radiotherapy in Locally Advanced Non‐Small Cell Lung Cancer

Yonglong Liu iD, Ningyi Ma, Yaqi Li, Jing Mi, Xingwen Fan iD, Jian Chen, Jingfang Mao, Guoliang Jiang, Kailiang Wu iD

Cancer Medicine · 2026

DOI: 10.1002/cam4.72229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Yonglong Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Heavy Ion Radiotherapy, Lung Neoplasms, Photons. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Carbon ion radiotherapy (CIRT) delivers high linear energy transfer radiation with superior dose conformity compared with photon radiotherapy (PRT). However, whether these physical advantages translate into clinical benefit for locally advanced non‐small cell lung cancer (LA‐NSCLC) in the era of modern systemic therapy remains unclear.

Methods

We performed a retrospective, propensity score‐matched cohort study of patients with Stage III LA‐NSCLC treated with definitive CIRT or PRT as part of multimodality therapy between January 2016 and December 2023. The primary endpoint was locoregional recurrence‐free survival (LRFS). Secondary endpoints included progression‐free survival (PFS), overall survival (OS), distant metastasis‐free survival (DMFS), and acute grade ≥ 2 radiation‐related adverse events (AEs).

Results

A total of 292 patients were matched (146 per group). With a median follow‐up of 32.5 months, CIRT group demonstrated significantly longer median LRFS (57.7 vs. 25.0 months; HR, 0.59; 95% CI, 0.39–0.88; p = 0.01) and median PFS (17.7 vs. 16.7 months; HR, 0.70; 95% CI, 0.53–0.94; p = 0.02) compared with PRT group, whereas OS and DMFS were similar between groups. CIRT group also had fewer acute grade ≥ 2 radiation‐related AEs.

Conclusions

CIRT demonstrated improved locoregional control and fewer acute toxicities compared with PRT in LA‐NSCLC in this retrospective matched cohort. Prospective randomized trials are warranted to validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungHeavy Ion RadiotherapyLung NeoplasmsPhotonsNeoplasm Recurrence, LocalHumansRetrospective StudiesFemaleMaleAgedMiddle Aged

Stichwörter der Autor:innen

carbon ion radiotherapylocoregional recurrence‐free survivalnon‐small cell lung cancerphoton radiotherapyprogression‐free survival

Autor:innen und Institutionen

  • Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.
  • Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
  • Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.
  • Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Shanghai Clinical Research Center for Radiation Oncology, Shanghai, China.

ORCID-Profile: Yonglong Liu, Xingwen Fan, Kailiang Wu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Ma, N., Li, Y., Mi, J., Fan, X., Chen, J., Mao, J., Jiang, G., & Wu, K. (2026). Improved Locoregional Recurrence‐Free Survival With Carbon Ion Versus Photon Radiotherapy in Locally Advanced Non‐Small Cell Lung Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.72229

Vancouver

Liu Y, Ma N, Li Y, Mi J, Fan X, Chen J, et al. Improved Locoregional Recurrence‐Free Survival With Carbon Ion Versus Photon Radiotherapy in Locally Advanced Non‐Small Cell Lung Cancer. Cancer Medicine. 2026. doi:10.1002/cam4.72229

BibTeX
@article{Liu2026,
  author = {Liu, Yonglong and Ma, Ningyi and Li, Yaqi and Mi, Jing and Fan, Xingwen and Chen, Jian and Mao, Jingfang and Jiang, Guoliang and Wu, Kailiang},
  title = {Improved Locoregional Recurrence‐Free Survival With Carbon Ion Versus Photon Radiotherapy in Locally Advanced Non‐Small Cell Lung Cancer},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72229}
}
Kostenlos starten →